In the second quarter of 2020, the utilization capacity of the pharmaceutical manufacturing industry was 74.0%

Pharmaceutical Network Market Analysis" has now entered the third quarter, looking back on the past second quarter, China's industrial capacity utilization situation? According to the National Bureau of Statistics, the national industrial capacity utilization rate in the second quarter of 2020 was 74.4%, down 2.0 percentage points from a year earlier and 7.1 percentage points higher than in the first quarterIn the first half of the year, the national industrial capacity utilization rate was 71.1%, down 5.1 percentage points from a year earlierCapacity utilization is the ratio of actual output to productive capacity, measured in valueThe actual output of an enterprise refers to the total industrial output value of the enterprise during the reporting period, while the production capacity of the enterprise refers to the output of the product spent in the reporting period, under the condition of ensuring the supply of labor, raw materials, fuel, transportation, etc., the production equipment (machinery) is maintained normally, and the enterprise can realize and maintain the product output for a long timePharmaceutical manufacturing (source: pharmaceutical network) pharmaceutical manufacturing capacity utilization rate in the second quarter of 74.0% from the industry classification, of which, the pharmaceutical manufacturing industry in the second quarter of capacity utilization rate of 74.0%, 3.6 percentage points lower than the same period last yearCumulative capacity utilization in the first half of the year was 72.7%, down 4.8 percentage points from the same period a year earlierPharmaceutical manufacturing refers to the resources in accordance with market requirements, through the processing and manufacturing process, into people can use the medical industrial products and consumer goods industryAccording to the industry classification, the pharmaceutical manufacturing industry includes seven sub-sectors of the manufacture of raw pharmaceutical drugs, the manufacture of chemical preparations, the processing of Chinese medicine tablets, the manufacture of traditional Chinese medicine, the manufacture of veterinary medicines, the manufacture of biological and biochemical products and the manufacture of sanitary materials and pharmaceutical productsTaken together, the pharmaceutical industry's capacity utilization in the second quarter was down from a year earlier, but the second quarter's capacity utilization increased by 3% compared with the first quarterIt can be seen that into the second quarter, the actual output of the pharmaceutical manufacturing industry gradually increased, the production capacity of enterprises is recoveringThe industry still has a good development space and prospects It is known that since the first half of this year, investment in high-tech fields continued to increase, of which investment in the pharmaceutical industry increased by more than 10%It can be seen that the pharmaceutical industry has attracted the attention and favor of the capital marketLooking forward to the future development of the pharmaceutical manufacturing industry, the industry is generally optimistic about its growth space, the reasons for making judgments are mainly based on policy and market demandAmong them, in terms of policy, with the promotion of policies such as volume procurement, generic drug consistency evaluation, medical insurance control fees, environmental protection, the pharmaceutical landscape has changed, and the industry is facing transformation and upgradingIn this context, some small and medium-sized enterprises that are not standardized enough, weak capital strength, and do not meet the environmental protection requirements of small and medium-sized enterprises will face the choice of transformation, merger and acquisition or elimination, and enterprises with strong research and development capabilities, sales capacity and product quality advantages will usher in development opportunities, the future trend of industry integration will accelerate, industry concentration is expected to increaseIn terms of market demand, medicine is just in demand, with the acceleration of the aging process of the population, the health insurance system continues to improve, residents' ability to pay and other factors, people's demand for pharmaceutical products will continue to expand, which will also drive the development of pharmaceutical manufacturing industryIn general, with the recovery of pharmaceutical manufacturing production accelerating and production capacity expansion, the overall supply and demand situation will maintain a good development trend The industry still has good development space and prospects Recently, there are pharmaceutical companies on the Internet roadshow also said that the pharmaceutical manufacturing industry is currently in a high-speed development stage, the company will further consolidate its market position in the industry, expand the scale of production, improve business performance